RxDoctor Payments Data

Joseph Carrozza, MD

Cardiovascular Disease · Brighton, MANPI 1639104714

Payments from drug & device makers

$20,404in general payments, 2019–2025

Across 19 payments — averaging $1073.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • Abbott$8K
  • Edwards Lifesciences$700
$8,125in research payments, 2019–2025

Across 2 payments — averaging $4062.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$8K

What the payments were for

  • Consulting fees$6,00084%
  • Speaking & faculty fees$70010%
  • Food & beverage$4046%

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)9$11,254
Abbott9$8,450
Edwards Lifesciences1$700

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,404 in reported general payments places this provider in the 75th percentile of 750 cardiovascular disease providers in Massachusetts.

See all cardiovascular disease providers in Massachusetts

Medicare billing

Part B allowed, 2024
$113,702
Medicare patients
343
Services billed
974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Brighton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →